Device Trial Radar · NCT07224256
VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Last checked: Nov 19, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
6
Planned (sponsor's estimate)
Start
Oct 3, 2025
Primary completion
Oct 2028
Study completion Oct 2031
Sponsor
- Lead sponsor
- Neuralink CorpNot on our public-company list
- Sponsor type
- Industry
- First posted
- Nov 4, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irreversible speech production impairment. It is indicated for adults with neurological conditions of the central speech pathways who have impaired upper limb function. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
Conditions
- Tetraplegia/Tetraparesis
- Quadriplegia
- Cervical Spinal Cord Injury
- Amyotrophic Lateral Sclerosis
- Quadriplegia/Tetraplegia
- Tetraplegic; Paralysis
- Stroke
Interventions
N1 ImplantDevice
The N1 Implant is a type of implantable brain-computer interface
R1 RobotDevice
The R1 Robot is a robotic electrode thread inserter that implants the N1 Implant.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Device-Related Adverse Events (AE)Time frame: 12 months post-implant
- Procedure-Related Adverse Events (AE)Time frame: 12 months post-implant
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The University of Texas Southwestern Medical Center
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.